Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.800 +0.070 (+4.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
36 37 Next >
News headline image
As Covaxin Catalyst Fades, Stay Away From Ocugen Stock ↗
It may be making progress with another candidate in its pipeline, but as it ceases to be a vaccine play, OCGN stock will head lower. 
Via InvestorPlace
News headline image
Christmas Is a Time for Ocugen Shareholders to Give Thanks ↗
This time last year, Ocugen traded below 30 cents. Up 1,683% since, owners of OCGN stock ought to be grateful for their unexpected returns. 
Via InvestorPlace
News headline image
Nio Day 2022: 13 Things for Nio Stock Investors to Expect on Dec. 18 ↗
Nio (NIO) Day is quickly approaching and there are loads of rumors about electric vehicle (EV) reveals that have investors excited today. 
Via InvestorPlace
News headline image
EV Stocks Outlook for 2022: Why One Analyst Sees Investor Enthusiasm Cooling Next Year ↗
One analyst believes the outlook for electric vehicle (EV) stocks in 2022 won't offer the same support it has during the current year. 
Via InvestorPlace
News headline image
Ocugen Partnered COVID-19 Vaccine Candidate Generates Immune Memory At Least 6 Months After Vaccination ↗
Ocugen Inc (NASDAQ: OCGN) announced that immune response data following two doses of Covaxin from a third-party study were published on the preprint server, ... 
Via Benzinga
News headline image
OCGN Stock Moves Higher on New Vaccine Data. What to Know. ↗
Shares of OCGN stock are getting some relief today and moving higher on positive results for its vaccine candidate. 
Via InvestorPlace
News headline image
What's Going On With Ocugen Stock Today ↗
Ocugen Inc. (NASDAQ:OCGN) shares are trading lower Tuesday... 
Via Benzinga
News headline image
How Worrisome Is Ocugen's Latest Bad News? ↗
Investors don't need to be too concerned about the FDA's clinical hold on a Covaxin study-- for now. 
Via The Motley Fool
News headline image
How Are The Shorts Feeling About Ocugen Inc? ↗
What happened: Ocugen Inc's (NASDAQ:OCGN) short interest has fallen 14% since the last report. The company recently reported that it has 46 million shares sold short, which is... 
Via Benzinga
News headline image
RNG Stock Alert: The COO News That RingCentral Investors Hanging Up Their Shares Today ↗
RingCentral (RNG) stock isn't doing so hot on Thursday with heavy trading after the company announced a change in leadership. 
Via InvestorPlace
News headline image
Investor Fears About Covaxin Have Ocugen Shares on Sale ↗
OCGN stock at this point is either an inexpensive Covid-19 vaccine stock or an over-priced investigational gene therapy stock — or both. 
Via InvestorPlace
News headline image
RENN Stock Alert: Why “Facebook of China” Renren Is Plunging Today ↗
Renren (RENN) stock is falling hard on Thursday following an update on a $300 million court case against the Facebook of China. 
Via InvestorPlace
Topics Lawsuit
News headline image
OCGN Stock Pops on Key FDA News. Here’s What to Know. ↗
Ocugen is slipping today even after promising news breaks related to its gene therapy program, OCU400. Where is OCGN stock heading? 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
News headline image
2 Big Stock Bets That Are Insiders Are Buying Now ↗
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. 
Via InvestorPlace
News headline image
Ocugen Investors Are Betting On a Horse Than Can’t Win the Race ↗
Don't go bottom-fishing with OCGN stock even if it's at an enticing support level 
Via InvestorPlace
News headline image
Ocugen Looks Risky as Markets Tire Of Speculative Vaccine Plays ↗
The window of opportunity is closing for also-ran vaccine makers, which is why OCGN has become a very volatile stock in the vaccine space. 
Via InvestorPlace
News headline image
Ocugen Stock Very Well May Have Bottomed Out Here ↗
I don’t know if InvestorPlace’s Larry Ramer is still short, but if he is, he’s made a few bucks with OCGN stock down in the past month. 
Via InvestorPlace
News headline image
Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail? ↗
Smaller companies are working on next-generation approaches to Covid treatment. 
Via Investor's Business Daily
News headline image
20 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results... 
Via Benzinga
News headline image
56 Biggest Movers From Friday ↗
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on... 
Via Benzinga
News headline image
OCGN Stock Alert: The FDA News Sending Ocugen Plummeting Today ↗
Shares of OCGN stock are under pressure after the FDA halted the approval process of Covaxin, a major setback for Ocugen. 
Via InvestorPlace
News headline image
48 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded... 
Via Benzinga
News headline image
Ocugen Shares Fall After Its Pivotal COVID-19 Vaccine Trial Put On FDA Hold ↗
The FDA has issued a clinical hold on Ocugen Inc's (NASDAQ: OCGN) Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate,... 
Via Benzinga
News headline image
25 Stocks Moving in Friday's Pre-Market Session ↗
Gainers iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-... 
Via Benzinga
News headline image
3 Small-Cap COVID Stocks With Huge Upside ↗
Three Fool.com contributors are bullish on Beyond Air, Ocugen, and Fulgent Genetics. 
Via The Motley Fool
News headline image
Think Twice Before You Roll the Dice on Ocugen Stock ↗
OCGN stock may spike once again on positive news, but investors' best best is to steer clear of it at this point in time. 
Via InvestorPlace
News headline image
Ocugen-Partnered Bharat Biotech's COVID-19 Shot Shows 50% Effectiveness In Small Study In India ↗
Bharat Biotech's vaccine was found to be 50% effective at preventing symptomatic COVID-19 in a high-risk population during the second wave of infections in India this year,... 
Via Benzinga
News headline image
Better Buy: Ocugen or Novavax? ↗
Will either of these hopeful vaccine makers continue to thrash the market? 
Via The Motley Fool
News headline image
Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen ↗
Both vaccine makers still have big hurdles to jump. 
Via The Motley Fool
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.